Despite the different SCLC subtypes and contexts, these data point to a central role of IGF-1R signaling in regulating the survival and proliferation of ASCL1High and POU2F3High SCLC cells, which warrants further studies to explore therapeutic strategies targeting this important pathway in these two subtypes of SCLC. The gene discussed is IGF1R; the disease is small cell lung carcinoma.